English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
 Local TagsRelease HistoryDetailsSummary
  Acetylcysteine for prevention of contrast nephropathy: meta-analysis

Birck, R., Krzossok, S., Markowetz, F., Schnulle, P., van der Woude, F. J., & Braun, C. (2003). Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet, 362(9384), 598-603.

Item is

 

show all hide all

Basic

show hide
Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0010-89C8-5 Version Permalink: https://hdl.handle.net/11858/00-001M-0000-0010-89C9-3
Genre: Journal Article
Alternative Title : Lancet

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Birck, Rainer, Author
Krzossok, Stefan, Author
Markowetz, Florian1, Author
Schnulle, Peter, Author
van der Woude, Fokko J., Author
Braun, Claude, Author
Affiliations:
1Max Planck Society, ou_persistent13              

Content

show
hide
Free keywords: -
 Abstract: Background Contrast nephropathy is associated with increased in-hospital morbidity and mortality and leads to extension of hospital stay in patients with chronic renal insufficiency. Acetylcysteine seems to be a safe and inexpensive way to reduce contrast nephropathy. We aimed to assess the efficacy of acetylcysteine to prevent contrast nephropathy after administration of radiocontrast media in patients with chronic renal insufficiency. Methods We did a meta-analysis of randomised controlled trials comparing acetylcysteine and hydration with hydration alone for preventing contrast nephropathy in patients with chronic renal insufficiency. The trials were identified through a combined search of the BIOSIS+/RRM, MEDLINE, Web of Science, Current Contents Medizin, and The Cochrane Library Databases. We used incidence of contrast nephropathy 48 h after administration of radiocontrast media as an outcome measure. Findings Seven trials including 805 patients were eligible according to our inclusion criteria and were analysed. Overall incidence of contrast nephropathy varied between 8% and 28%. Since significant heterogeneity was indicated by the Q statistics (p=0·016) we used a random-effects model to combine the data. Compared with periprocedural hydration alone, administration of acetylcysteine and hydration significantly reduced the relative risk of contrast nephropathy by 56% (0·435 [95% CI 0·215–0·879], P=0·02) in patients with chronic renal insufficiency. Meta-regression revealed no significant relation between the relative risk of contrast nephropathy and the volume of radiocontrast media administered or the degree of chronic renal insufficiency before the procedure. Interpretation Compared with periprocedural hydration alone, acetylcysteine with hydration significantly reduces the risk of contrast nephropathy in patients with chronic renal insufficiency. The relative risk of contrast nephropathy was not related to the amount of radiocontrast media given or to the degree of chronic renal insufficiency before the procedure.

Details

show
hide
Language(s): eng - English
 Dates: 2003-08-23
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: eDoc: 173616
ISI: 000184904100007
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Lancet
  Alternative Title : Lancet
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 362 (9384) Sequence Number: - Start / End Page: 598 - 603 Identifier: ISSN: 0140-6736